Sign in Subscribe

Archive

A collection of 364 issues

Latest

Colon capsule endoscopy system evaluated in multicenter study as noninvasive screening alternative

Skip to content The CRC Digest ▪ SCREENING Colon capsule endoscopy system evaluated in multicenter study as noninvasive screening alternative A prospective multicenter study at three hospitals in China assessed the CC100 colon capsule endoscopy system's diagnostic accuracy and complete visualization rates, offering a minimally invasive alternative to conventional

Colonoscopy linked to lower CRC risk in adults aged 75–85 in Korean nationwide study

Skip to content The CRC Digest ▪ SCREENING Colonoscopy linked to lower CRC risk in adults aged 75–85 in Korean nationwide study In a study of adults aged 75 to 85, two matched cohorts of 19,005 individuals each were compared: colonoscopy was associated with a reduced incidence of colorectal

Blood-based cfDNA test trial aims to reduce CRC screening disparities

Skip to content The CRC Digest ▪ SCREENING Blood-based cfDNA test trial aims to reduce CRC screening disparities A randomized trial is underway to test whether offering an FDA-approved cell-free tumor DNA blood test as an expanded screening option improves participation rates, especially among lower-income and racial/ethnic minoritized groups who

Severe immune-related side effects studied in 1,175 MSI-H digestive cancer patients on immunotherapy

Skip to content The CRC Digest ♥ LIVING WITH CRC Severe immune-related side effects studied in 1,175 MSI-H digestive cancer patients on immunotherapy An international study of 1,175 patients from 34 centers examined how grade 3 or higher immune-related adverse events correlate with progression-free survival and overall survival in

RAS and BRAF mutations may predict different immunotherapy outcomes in MSI-H/dMMR metastatic CRC

Skip to content The CRC Digest ◇ RESEARCH RAS and BRAF mutations may predict different immunotherapy outcomes in MSI-H/dMMR metastatic CRC A meta-analysis found that oncogenic driver mutations like RAS and BRAF may contribute to clinically meaningful differences in how MSI-H/dMMR metastatic colorectal cancer responds to immune checkpoint inhibitors,

Expert Consensus Calls for Sex and Gender-Tailored CRC Screening

Skip to content The CRC Digest Expert Consensus Calls for Sex and Gender-Tailored CRC Screening An Italian consensus study from the AIOM-GISEG working group identified areas of expert agreement regarding the potential appropriateness and clinical relevance of sex and gender-tailored colorectal cancer screening strategies, noting that despite evidence of sex

CT-Based Imaging Biomarker May Predict MSI Status

Skip to content The CRC Digest CT-Based Imaging Biomarker May Predict MSI Status A retrospective study of 121 CRC patients investigated whether CT-derived extracellular volume fraction can predict microsatellite instability status non-invasively. (American Journal of Translational Research) This content is informational only and does not constitute medical advice. Always consult

Gut Microbiota Differs Between MSI-H and MSS Colorectal Cancer

Skip to content The CRC Digest Gut Microbiota Differs Between MSI-H and MSS Colorectal Cancer A study collected fecal samples from CRC patients with different microsatellite states and healthy individuals to explore differences in gut microbiota between MSI-H and MSS colorectal cancer, potentially providing new directions for immunotherapy in MSS

Latent Profile Analysis Identifies Distinct Quality of Life Patterns in CRC Survivors

Skip to content The CRC Digest Latent Profile Analysis Identifies Distinct Quality of Life Patterns in CRC Survivors Researchers used latent profile analysis of EORTC quality of life questionnaires to identify distinct health-related quality of life profiles among colorectal cancer patients, aiming to inform more personalized follow-up strategies. (Colorectal Disease)

Patient-Provider Relationship Quality Linked to Screening Uptake

Skip to content The CRC Digest Patient-Provider Relationship Quality Linked to Screening Uptake A national study using HINTS data from 7,732 US adults aged 45-75 found that patient-provider relationship quality may influence colorectal cancer screening uptake. (Cureus) This content is informational only and does not constitute medical advice. Always